National Cancer Center, Korea
Clinical trials sponsored by National Cancer Center, Korea, explained in plain language.
-
New bladder cancer treatment trial offers hope when standard therapy fails
Disease control Recruiting nowThis study is testing whether washing the bladder with two cancer drugs, one after the other, can help control high-risk bladder cancer in patients whose cancer did not respond to the standard BCG treatment. The trial aims to see if this approach can prevent the cancer from comin…
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Radiation boost for liver cancer treatment?
Disease control Recruiting nowThis study is testing whether adding a targeted form of radiation therapy to standard immunotherapy helps people with advanced liver cancer that has grown into major blood vessels. It will enroll 128 patients to compare how long the cancer stays under control and how long patient…
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Can a second surgery extend lives for women with recurring ovarian cancer?
Disease control Recruiting nowThis study is testing whether performing surgery after chemotherapy helps women with recurrent ovarian cancer live longer without their cancer getting worse. It will compare two groups: one that gets surgery plus chemotherapy, and one that gets chemotherapy alone. The researchers…
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Hot chemo bath tested in major ovarian cancer trial
Disease control Recruiting nowThis large study is testing whether washing the abdomen with heated chemotherapy during surgery helps people with advanced ovarian cancer live longer. It will compare surgery with the heated chemo treatment to surgery alone in 520 patients. The main goal is to see if this approac…
Phase: PHASE3 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC